中国经济网北京5月23日讯江苏恒瑞医药股份有限公司(简称“恒瑞医药”,01276.HK)今日在港交所上市。截至收盘,该股收报55.15港元,涨幅25.20%。 最终发售价及配发结果公告显示,恒瑞医药全球发售项下的发售股份数目为224,519,800股H股(视乎超额配股权行使与否而定)。其中,香港发售股份数目为48,271,800股H股(经重新分配后调整);国际发售股份数目为176,248,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.